Patents for A61P 13 - Drugs for disorders of the urinary system (56,135)
12/2006
12/14/2006WO2006132438A1 1,3-benzothiazinone derivative and use thereof
12/14/2006WO2006132321A1 Agent for preventing, ameliorating and treating phosphorus-induced disorder, oral preparation for adsorbing phosphate ion in food, drink or drug and method of producing the same
12/14/2006WO2006132295A1 Regulator of aldosterone receptor
12/14/2006WO2006132204A1 Transcription factor decoy
12/14/2006WO2006132196A1 NOVEL PHARMACEUTICAL COMPRISING β3 AGONIST
12/14/2006WO2006111776A3 Pharmaceutical composition comprising serum obtained from a naive mammal
12/14/2006WO2006085079A3 Pharmaceutically active phosphate binders, their manufacture, compositions containing them and their use
12/14/2006WO2001022972A9 Immunostimulatory nucleic acids
12/14/2006US20060281905 Crystallization of IGF-1
12/14/2006US20060281812 For urogenital disorders; improved side effect reduction, bioavailability, pharmacokinetics and half-life; N,N-diisopropyl-3-(2-methoxy-5-trifluoromethylphenyl)-3-phenylpropanamine tartrate
12/14/2006US20060280719 An addition polymer from an unsaturated monomer containing a phosphonate group and a phosphinate group separated from eachother by an optionally fluorinated methylene group; treatment of hyperphosphotemia, chronic renal failure, hyperparathyroidism, uremic bone disease, or osteoporosis
12/14/2006US20060280681 Food for testing life style-related diseases
12/14/2006CA2614295A1 Transcription factor decoy
12/13/2006EP1731523A1 Thiazolopyrimidine derivative
12/13/2006EP1731520A1 Pyrrolo[2,3-d]pyrimidine derivatives which are antagonists of adenosine A1, A2A, and A3
12/13/2006EP1731502A1 Novel crystal of triterpene derivative
12/13/2006EP1731169A1 Remedies for prostatic hypertrophy
12/13/2006EP1731157A2 Pharmaceutical compositions and uses for androst-5-ene-3 beta,17 beta-diol
12/13/2006EP1729756A2 Novel pharmaceutical compositions
12/13/2006EP1729749A2 Use of renin inhibitors in therapy
12/13/2006EP1596856B1 Drugs containing substituted 2-aryl-aminoacetic acid compounds and/or substituted 2-heteroaryl-aminoacetic acid compounds
12/13/2006EP1427424A4 Lpa receptor agonists and antagonists and methods of use
12/13/2006EP1383765B1 Carboline derivatives as inhibitors of phosphodiesterase 5 (PDE5) for the treatment of cardiovascular diseases and erectile dysfunction
12/13/2006EP1197143B1 Goodpasture's syndrome model mouse
12/13/2006EP1123392B1 Prv-1 gene and the use thereof
12/13/2006CN1878557A Pharmaceutical compositions for the treatment of renal dysfunction, disease or disorder, in particular in diabetic patients
12/13/2006CN1878552A Methods of use of thrombin receptor antagonists
12/13/2006CN1876683A Human antibodies that bind human TNFalpha
12/13/2006CN1876641A Method for purifying salvianolic acid B
12/13/2006CN1876149A A medicinal liquor for treating spleen-qi deficiency type nephritis and preparation method thereof
12/13/2006CN1876145A A medicinal liquor for treating kidney-yin deficiency type turbid urine and preparation method thereof
12/13/2006CN1876143A A Chinese medicine for treating glomerulonephritis, kidney function failure and nephrotic syndrome
12/13/2006CN1876141A A Chinese medicinal enteroclysis for treating damp heat type chronic prostatitis
12/13/2006CN1876137A A medicinal liquor for treating yin-evil remained type nephritis and preparation method thereof
12/13/2006CN1876105A A medicinal liquor for treating kidney-yin deficiency type nephritis and preparation method thereof
12/13/2006CN1876091A A medicinal liquor for treating type turbid urine syndrome and preparation method thereof
12/13/2006CN1876088A A medicine for treating chronic prostatitis and preparation method thereof
12/13/2006CN1876073A Pharmaceutical composition for treating urinary system disease
12/13/2006CN1876050A Pharmaceutical preparation for treating prostatitis, its preparation process and quality control method
12/13/2006CN1876033A Compound Chinese preparation with gingko, its preparation method and use
12/13/2006CN1876031A Chinese globe flower injection and preparation method thereof
12/13/2006CN1876029A A medicine for treating uremia and diabetes
12/13/2006CN1876024A Quality control method of pharmaceutical preparation for treating liver and kidney disease
12/13/2006CN1875976A Use of tanshinone compound in preparation of medicine for treating prostate hyperplasia
12/13/2006CN1875971A Preparation process of gatifloxacin injection
12/13/2006CN1289499C Pirazino (aza) indole derivatives
12/13/2006CN1289497C 2-(3,5-bis-trifluoromethyl-phenyl)-N-[6-(1.1-dioxo-1 lambda b-thiomorpholin-4-yl)-4-(methyl or 4-fluoro-2-methyl substituted)phenyl-pyridin-3-yl]-N-methyl-isobutyramide
12/13/2006CN1289471C 3,4-di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands
12/13/2006CN1289455C 2-(2,6-dichlorophenyl)-diarylimidazoles
12/13/2006CN1289125C Chinese medicine sitting bathing preparation for treating chronic prostatitis and its preparing method and use
12/13/2006CN1289116C Medicine for treating chronic prostatitis, and its preparation method
12/13/2006CN1289102C Chinese-western medicine compound suppository for treating prostatic diseases
12/13/2006CN1289090C Highly selective norepinephrine reuptake inhibitors and use thereof in medicament preparation
12/13/2006CN1289087C Quinoline derivatives as neuropeptide y antagonists
12/13/2006CN1289074C Method for preparing sodium ferulate sterilized raw-material medicine
12/12/2006US7148337 drug target and diagnostic marker for prostate cancer; host cells and expression vectors
12/12/2006US7148247 Substituted benzoxazoles as estrogenic agents
12/12/2006US7148233 Treatment of cardiovascular and related pathologies
12/12/2006US7148220 Tyrosine kinase enzyme inhibitors as growth factor receptors and useful as antiproliferation agents
12/12/2006US7147876 comprises Aloe vera, Vitamins, mineral concentrate, organic oils concentrate, Chinese herb, essential oil and spice; for medicinal/cosmetic use
12/12/2006CA2347741C Thiazole-derivatives
12/12/2006CA2121871C A prophylactic or therapeutic drug for renal diseases
12/12/2006CA2098176C Angiotensin ii receptor blocking compositions
12/07/2006WO2006130745A1 Macromolecular conjugates of bone morphogenetic protein-7
12/07/2006WO2006129826A1 Novel piperidine derivative
12/07/2006WO2006129785A1 Concomitant pharmaceutical agents and use thereof
12/07/2006WO2006129784A1 INTERFERON-α REGULATOR
12/07/2006WO2006129679A1 Spiropiperidine compound and medicinal use thereof
12/07/2006WO2006129623A1 Thienotriazolodiazepine compound and a medicinal use thereof
12/07/2006WO2006129587A1 Pharmaceutical composition comprising pyrazolone derivative
12/07/2006WO2006129524A1 Carbonyl compound remover
12/07/2006WO2006129076A1 Use of a steroid sulphatase inhibitor for inhibiting the synthesis of androstenedione and/or testosterone
12/07/2006US20060276645 Novel carboxylic acid derivatives, their preparation and use
12/07/2006US20060276531 Agent for the treatment of bladder irritative symptoms accompanied by benign prostatic hyperplasia
12/07/2006US20060276518 Aryl and heteroaryl compounds and methods to modulate coagulation
12/07/2006US20060276516 Inhibitors of kinases and treatment of diseases mediated by cytokines produced by p38
12/07/2006US20060276488 (Anilino)(halo)pyrimidine derivatives or (anilino)(amino)pyrimidine derivatives; treating rheumatoid arthritis, psoriasis, Crohn's Disease, osteoarthritis or osteoporosis.
12/07/2006US20060276474 Novel carboxylic acid derivatives, their preparation and use
12/07/2006US20060276456 Such as [1,1-biphenyl]-4-yl-(5,11-dihydro-10H-dibenzo[b,e][1,4]diazepin-10-yl)methanone; for treatment of diabetes insipidus, nocturnal enuresis, nocturia, urinary incontinence, or hemophilia
12/07/2006US20060276421 single-stranded oligonucleotide comprising a 5'-end sequence, an intermediate sequence and a 3'-end sequence, both ends having reverse complementarity with the intermediate sequence, intermediate sequence having loops at both ends; phosphate groups are not phosphorothioated; antiinflammatory agent
12/07/2006US20060276397 Crystallization of IGF-1
12/07/2006US20060276396 Stimulating insulin synthesis and release, enhancing adipose, muscle or liver tissue sensitivity towards insulin uptake, stimulating glucose uptake, slowing digestive process, or blocking the secretion of glucagon; glucagon-like protein
12/07/2006US20060276384 Peptides and medicinal compositions containing the same
12/07/2006US20060275359 Palliative effects of morinda citrifolia oil and juice
12/07/2006US20060275304 Novel tumor antigen useful in diagnosis and therapy of prostate and colon cancer
12/07/2006US20060275287 Scroll compressor
12/07/2006US20060275284 Combination therapy for treatment of autoimmune diseases using b-cell depleting/immunoregulatory antibody combination
12/07/2006US20060275253 Beta hydroxy short to medium chain fatty acid polymer
12/07/2006CA2609818A1 Use of a steroid sulphatase inhibitor for inhibiting the synthesis of androstenedione and/or testosterone
12/07/2006CA2609388A1 Novel piperidine derivative
12/06/2006EP1728801A1 Subtype of humanized antibody against interleukin-6 receptor
12/06/2006EP1728800A1 Papilloma virus-like particles, fusion proteins and process for producing the same
12/06/2006EP1728791A1 Composition for solid pharmaceutical preparation of solifenacin or salt thereof
12/06/2006EP1728518A1 Method of diagnosing monitoring, staging, imaging and treating gynecologic cancers and testicular cancer
12/06/2006EP1728508A1 Medicine for prevention or treatment of frequent urination or urinary incontinence
12/06/2006EP1728504A1 Emulsion stabilizer
12/06/2006EP1727534A2 Hydroxymethylbutyrate compositions and uses thereof
12/06/2006EP1727523A2 Pharmaceutical formulation containing unmilled flutamide
12/06/2006EP1456212B1 6-aminomorphinane derivatives, method for the production and use thereof
12/06/2006EP1438304B1 Novel substituted 4-phenyl-4-[1h-imidazol-2-yl]-piperidine derivatives and their use as selective non-peptide delta opioid agonists